You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)

Date Filed Document No. Description Snippet Link To Document
2022-05-20 144 Order on Motion for Summary Judgment Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”) and 10,426,787 (the “’787 patent,” and together…States Patent Application No. 15/173,961 ultimately issued as the ’895 patent. United States Patent Application…together with the ’895 patent, the “Combination Patents”). For the reasons that follow, Plaintiffs’ motion…903,785 ultimately issued as the ’787 patent. The Combination Patents have the same inventors, both claim…8362 Patent Application No. 15/903,785, which was filed on June 18, 2015, and the two patents have External link to document
2022-09-21 196 Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”), 10,426,787 (“the ’787 patent,” and together…together with the ’895 patent, the “Combination Patents”), 8,809,307 (“the ’307 patent”) and 10,478,502 (…reduction . . .” (Claim 1 of the ‘787 patent; claim 1 of the ‘895 patent.) The language of the relevant…produces” test has a foundation in either the patents or patent law; this Court rejects Defendants’ argument…starring role in the patent specifications, as IDP-118 has in the Combination Patents. There is nothing External link to document
2022-11-30 246 Opinion Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”), 10,426,787 (“the ’787 patent,” and together…the ’502 patent,” and together with the ’307 patent, the “HP Patents”). All four patents are listed…the ’295 patent; 2) Blum, the ’295 patent and the ’566 patent; and 3) Blum, the ’295 patent, and JP…together with the ’895 patent, the “Combination Patents”), 8,809,307 (“the ’307 patent”) and 10,478,502 … of the’895 and ’787 Patents. ’895 Patent, at 11:30–20:10; ’787 Patent, at 11:30–20:8. External link to document
2021-10-06 75 Opinion concerning the ’307 Patent, the ’502 Patent, U.S. Patent Nos. 10,251,895 (the “’895 Patent”) and 10,426,787…infringement of U.S. Patent Nos. 8,809,307 (the “’307 Patent”) and 10,478,502 (the “’502 Patent”) through Padagis…prosecution of a patent application has a duty of candor and good faith in dealing with the [Patent] Office, …and ’787 patents being declared invalid. Padagis therefore seeks a judgment that these patents are unenforceable… Bryhali, wherein Padagis alleged that these patents are invalid, unenforceable, and/or will not be External link to document
2021-11-03 83 Order AND Opinion owns U.S. Patent Nos. 8,809,307 (“the ’307 patent”), 10,478,502 (“the ’502 patent”), 10,251,895 (“the ’…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…claim 1 of the ‘895 patent and claim 1 of the ‘787 patent. Claim 1 of the ‘895 patent is representative…and 22 of the ‘307 patent and claim 1 of the ‘502 patent. Claim 1 of the ‘502 patent states: … ’895 patent”), and 10,426,787 (“the ’787 patent”). The parties seek claim construction of terms in External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.